Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?

@article{Lehmann2017ClinicalMS,
  title={Clinical mass spectrometry proteomics (cMSP) for medical laboratory: What does the future hold?},
  author={Sylvain Lehmann and Cato Brede and Pierre Lescuyer and Jos{\'e} A. Cocho and J{\'e}r{\^o}me Vialaret and P Cubero Bros and Vincent Delatour and Christophe Hirtz},
  journal={Clinica chimica acta; international journal of clinical chemistry},
  year={2017},
  volume={467},
  pages={
          51-58
        }
}
BACKGROUND Mass spectrometry (MS) methods are being widely used these days in medical laboratories for quantifying many small molecular analytes as well as for microbiological purposes. METHODS Little use has been made so far, however, of MS for analyzing peptides and proteins in clinical laboratory (an approach known as clinical MS proteomics (cMSP)). The explanation for this situation may be that cMSP assays are more complex to implement than conventional assays, require large investments… CONTINUE READING
BETA
14
Twitter Mentions

Tables and Topics from this paper.

Explore Further: Topics Discussed in This Paper

References

Publications referenced by this paper.
SHOWING 1-10 OF 72 REFERENCES

Evaluation of the detection capabilities for clinical laboratory measurement procedure; approved guideline

JF VJPierson-Perry, AP Durhamn, +5 authors RA Middelberg
  • Second Edition,
  • 2012
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Critical assessment of accelerating trypsination methods.

  • Journal of pharmaceutical and biomedical analysis
  • 2011
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Approved IFCC reference method for the measurement of HbA1c in human blood.

  • Clinical chemistry and laboratory medicine
  • 2002
VIEW 3 EXCERPTS
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…